Robin Howard W, President and CEO of Nektar Therapeutics (NKTR), sold nearly $1 million worth of shares through 16 open market transactions over the last year, with the most recent on February 18, 2026. These sales rank 4,945th among over 11,700 individual insiders, below the average sale value of $8.6 million and 6.4 transactions per seller. Robin Howard W made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 423 | $73.00 | 75,517.0000 | 18,946,559 | 0.56% | 0.00% |
| Dec. 22, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | A | Stock Option | 86667 | $0.00 | 86,667.0000 | 18,946,559 | 9999.99% | 0.46% |
| Dec. 22, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | A | Common Stock | 21667 | $0.00 | 75,940.0000 | 18,946,559 | 39.92% | 0.11% |
| Nov. 21, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | A | Common Stock | 7110 | $0.00 | 56,480.0000 | 18,946,559 | 14.40% | 0.04% |
| Nov. 21, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | A | Stock Option | 12170 | $0.00 | 12,170.0000 | 18,946,559 | 9999.99% | 0.06% |
| Nov. 25, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 2207 | $54.28 | 54,273.0000 | 18,946,559 | 3.91% | 0.01% |
| Sept. 9, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 2156 | $47.49 | 50,580.0000 | 205,661,000 | 4.09% | 0.00% |
| Sept. 9, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 2100 | $45.16 | 53,936.0000 | 205,661,000 | 3.75% | 0.00% |
| Sept. 9, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 1200 | $46.41 | 52,736.0000 | 205,661,000 | 2.22% | 0.00% |
| Sept. 9, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 1210 | $48.18 | 49,370.0000 | 205,661,000 | 2.39% | 0.00% |
| Sept. 5, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 2226 | $38.82 | 57,172.0000 | 205,661,000 | 3.75% | 0.00% |
| Sept. 4, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 1923 | $32.37 | 65,945.0000 | 205,661,000 | 2.83% | 0.00% |
| Sept. 4, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 1496 | $33.54 | 64,449.0000 | 205,661,000 | 2.27% | 0.00% |
| Sept. 4, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 613 | $34.40 | 63,836.0000 | 205,661,000 | 0.95% | 0.00% |
| Sept. 4, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 1134 | $35.80 | 62,702.0000 | 205,661,000 | 1.78% | 0.00% |
| Sept. 5, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 3304 | $37.87 | 59,398.0000 | 205,661,000 | 5.27% | 0.00% |
| Sept. 5, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 1136 | $39.89 | 56,036.0000 | 205,661,000 | 1.99% | 0.00% |
| Sept. 2, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 1500 | $30.16 | 67,868.0000 | 205,661,000 | 2.16% | 0.00% |
| Aug. 19, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | A | Stock Option | 86666 | $0.00 | 86,666.0000 | 205,661,000 | 9999.99% | 0.04% |
| Aug. 19, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 1573 | $26.59 | 69,368.0000 | 205,661,000 | 2.22% | 0.00% |
| May 19, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 23208 | $0.67 | 1,064,103.0000 | 205,661,000 | 2.13% | 0.01% |
| Feb. 19, 2025 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 23774 | $1.01 | 1,087,311.0000 | 205,661,000 | 2.14% | 0.01% |
| Dec. 18, 2024 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 85035 | $0.99 | 1,111,085.0000 | 13,949,851 | 7.11% | 0.61% |
| Dec. 17, 2024 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 46995 | $1.01 | 1,196,120.0000 | 13,949,851 | 3.78% | 0.34% |
| Dec. 13, 2024 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | A | Stock Option | 1300000 | $0.00 | 1,300,000.0000 | 13,949,851 | 9999.99% | 9.32% |
| Dec. 13, 2024 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | A | Common Stock | 410625 | $0.00 | 1,243,115.0000 | 13,949,851 | 49.32% | 2.94% |
| Dec. 13, 2024 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | A | Stock Option | 821250 | $0.00 | 821,250.0000 | 13,949,851 | 9999.99% | 5.89% |
| Nov. 19, 2024 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 16278 | $1.01 | 832,490.0000 | 13,949,851 | 1.92% | 0.12% |
| Aug. 19, 2024 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 14881 | $1.28 | 848,768.0000 | 190,001,000 | 1.72% | 0.01% |
| May 17, 2024 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 16650 | $1.75 | 863,649.0000 | 190,001,000 | 1.89% | 0.01% |
| Feb. 20, 2024 | NEKTAR THERAPEUTICS | $NKTR | ROBIN HOWARD W | President & CEO | S | Common Stock | 20033 | $0.68 | 880,299.0000 | 190,001,000 | 2.23% | 0.01% |